|Articles|October 23, 2020
Rapid Readiness for Pandemic Response
Author(s)Emergent BioSolutions
In this ondemand webinar we discuss how drug developers can maximize capacity, capabilities, and expertise for pandemic response and how pharma and biotech innovators are working together to combat COVID-19.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
The FDA Moves to Modernize Drug Manufacturing Registration
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
4
It’s Time to Build a More Scalable, Connected CRO
5